Status:
COMPLETED
Important Correlation Between Anxiety and Reflux Symptoms in Patients With Gastroesophageal Reflux Disease
Lead Sponsor:
Evangelic Hospital Kalk Cologne
Conditions:
GERD - Gastro-Esophageal Reflux Disease
Anxiety Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Gastroesophageal reflux disease (GERD) is one of the most common gastroenterological disorders with a reported prevalence of 10% to 20% percent in Europe and the USA and less than 5% in Asia. GERD man...
Detailed Description
Introduction: Gastroesophageal reflux disease (GERD) is one of the most common gastroenterological disorders with a reported prevalence of 10% to 20% percent in Europe and the USA and less than 5% in...
Eligibility Criteria
Inclusion
- Patients with symptoms of reflux who present at the consultation hour at the department of General, Visceral, Tumor and Transplantation Surgery of the University Hospital of Cologne
- Patients who underwent Upper GI Endoscopy, High-Resolution Manometry and pH-Impedance testing who completed the HADS questionnaire were included into the study.
Exclusion
- Patients without knowledge of the German language
- Patients who did not complete the HADS questionnaire
- Patients who did not complete all diagnostic testing
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
458 Patients enrolled
Trial Details
Trial ID
NCT06151067
Start Date
January 1 2020
End Date
June 30 2022
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of General, Visceral, Tumor and Transplantation Surgery, University Hospital Cologne
Cologne, North Rhine-Westphalia, Germany, 50937